2023-09-30-accounts - Shine Cancer Support

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

					Page
Report of	the Trustees			I	to	7
Report of	the independent		Auditors	8	to	10
Statement	ofFinancial	Activities
Balance Sheet					12
Notes to the Financial		Statements		13	to	22

							2023	2022
					Unrestricted	Restricted	Total	Total
					fund	funds	funds	funds
				Notes
INCOME	AND ENDOWMENTS		FROM
Donations	and legacies			3	143,857	120,332	264,189	273,673
Charitable	activities
Charitable	activities				3,750		3,750	1,000
Other trading activities				4	4,337		4,337	3,614
Investment	income			5	3,138		3,138	174
Total					155,082	120,332	275,414	278,461
EXPENDITURE ON
Raising funds					11,035		11,035	8,236
Charitable	activities
Charitable	activities				133,461	120,801	254,262	208,065
Total					144,496	120,801	265,297	216,301
Net gains/(losses) on investments					8,631		8,631	(7,934)
NET INCOME/(EXPENDITURE)					19,217	(469)	18,748	54,226
Traasfers	between funds			15	34,482	(34,482)
Net movement in funds					53,699	(34,951)	18,748	54,226
RECONCILIATION		OF FUNDS
Total funds	brought forward				339,576	130,924	470,500	416,274
TOTAL FUNDS CARRIED FORWARD					393,275	95,973	489,248	470,500

				2023	2022
		Unrestricted	Restricted	Total	Total
		fund	funds	funds	funds
	Notes
FIXEDASSETS
Tangible assets	10	4,672		4,672	633
Investments	11	100,697		100,697	92,066
		105,369		105,369	92,699
CURRENT ASSETS
Debtors	12	2,001		2,001	1,139
Cash at bank and in band		302,333	95,973	398,306	384,170
		304,334	95,973	400,307	385,309
CREDITORS
Amounts falling due within one year	13	(16,428)		(16,428)	(7,508)
NET CURRENT ASSETS		287,906	95,973	383,879	377,801
TOTAL ASSETS LESSCURRENT
LiABILITIES		393,275	95,973	489,248	470,500
NET ASSETS		393,275	95,973	489,248	470,500
FUNDS	15
Unrestricted funds				393,275	339,576
Restricted funds				95,973	130,924
TOTAL FUNDS				489,248	470,500

					2023	2022
					f.
Donations					33,098	33,017
Gift aid					707
Grants					120,832	139,067
Sponsorship					69,241	88,632
Corporate					40,311	12,957
					264,189	273,673
Grants received,			included	in the above, are as follows:
					2023	2022
					8
The National		Lottety				9,930
Winston Churchill					5,975	5,975
Merck						8,802
Oak Foundation					86,360	91,360
Bristol-Myers		Squibb Pharmaceuticals				12,000
Charities	Trust					1,000
Takeda						10,000
The Light	Fund				5,000
GSK UK					5,275
Gilead Sciences					18,222
					120,832	139,067

														2023	2022	2022
	Fundraising events													190		1,145
	Shop income													157		72
	Other income													3,990		2,397
														4,337		3,614
5.	INVESTMENT INCOME
														2023	2022
																f.
	Interest receivable		-	trading										3,138		174
6.	SUPPORT COSTS
														Governance
												Management		costs	Totals
	Charitable	activities											1,084	47,987	49,071
	Included	within Governance				costs		is the	Audit fee		ofK5,900(2022:f5,550).
	TRUSTEES' REMUNERATION							AND		BENEFITS
														2023	2022
														f.
	Trustees'	salaries													95,254
	Trustees'	social security														6,160
	Trustees'	pension contributions					to	money	purchase		schemes					2,483
															103,897
	Trustees are remunerated				in	accordance			with the Charities			constitution	for work that falls outside oftheir			Trustee
	duties.
	Trustees'	expenses
														2023	2022
														f.
	Trustees'	expenses														81
	STAFF' COSTS
														2023	2022
														f,
	Wages and salaries													150,656	125,080
	Social security costs													9,106		7,530
	Other pension costs													3,012		2,945
														162,774	135,555
	The average monthly			number			ofemployees			during	the year	was as follows:
														2023	2022
	Members	ofstaff												5		4
										Page	15				continued. ..

No employees received	emoluments	in excess off60,000.
COMPARATIVES FOR THE STATEMENT OF FINANCIAL			ACTIVITIES
			Unrestricted	Restricted	Total
			fund	funds	funds
INCOME AND ENDOWMENTS		FROM
Donations and legacies			155,578	118,095	273,673
Charitable activities
Charitable activities			1,000		1,000
Other trading activities			3,614		3,614
Investment income			174		174
Total			160,366	118,095	278,46]
EXPENDITURE ON
Raising funds			8,236		8,236
Charitable activities
Charitable activities			115,511	92,554	208,065
Total			123,747	92,554	216,301
Net gains/(losses) on investments			(7,934)		(7,934)
NET INCOME			28,685	25,541	54,226
Transfers between funds			(288)	288
Net movement in fumls			28,397	25,829	54,226
RECONCILIATION	OF FUNDS
Total funds brought forward			311,179	105,095	416,274
TOTAL FUNDS CARRIED FORWARD			339,576	130,924	470,500

10.	TANGIBLE FIXED ASSETS	TANGIBLE FIXED ASSETS
				Computer
				equipment
	COSI'
	At I October 2022			2,227
	Additions			6,533
	At 30 September 2023			8,760
	DEPRECIATION
	At 1 October 2022			1,594
	Charge for year			2,494
	At 30 September 2023			4,088
	NET BOOK VALUE
	At 30 September 2023			4,672
	At 30 September 2022			633
11.	FIXEDASSET INVESTMENTS
				Listed
				investments
	MARKET VALUE
	At 1 October 2022			92,066
	Revaluations			8,631
	At 30 September 2023			100,697
	NET BOOK VALUE
	At 30 September 2023			100,697
	At 30 September 2022			92,066
	There were no investment	assets outside the UK.
12.	DEBTORS:AMOUNTS	FALLING DUE WITHIN ONE YEAR
			2023	2022
	Trade debtors		315
	Prepayments and accrued	income	1,686	1,139
			2,001	1,139

CREDITORS: AMOUNTS FALLING DUE WIT	HIN ONE YEAR
	2023	2022
	6
Trade creditors	8,359	954
Other creditors	489	404
Accrued expenses	7,580	6, 150
	16,428	7,508

				2023	2022
Within one year				3,960	906
Between one	and five years			5,280
				9,240	906
MOVEMENT IN FUNDS
			Net	Transfers
		At	movement	between	At
		1.10.22	ln funds	funds	30.9.23
Unrestricted	funds
General fund		339,576	19,217	34,482	393,275
Restricted funds
VBG camp		4,505			4,505
Lottery funding		7,118	(7,256)	138
M B Donation		11,593	(11,593)
Oak Foundation		100,834	(1,645)	(34,572)	64,617
Merck/lvlSP		899	(1,047)	148
Winston Churchill 2		5,975	3,555		9,530
GSK			196	(196)
Gilead			17,321		17,321
		130,924	(469)	(34,482)	95,973
TOTAL FUNDS		470,500	18,748		489,248

				Incoming	Resources	Gains	and	Movement
				resources	expended	losses		in funds
						8
Unrestricted	fumls
General fund				155,082	(144,496)	8,631		19,217
Restricted funds
Lottery funding					(7,256)			(7,256)
M BDonation				4,500	(16,093)			(11,593)
Oak Foundation				86,360	(88,005)			(1,645)
Merck/MSP					(1,047)			(1,047)
Winston Churchill		2		5,975	(2,420)			3,555
GSK				5,275	(5,079)			196
Gilead				18,222	(901)			17,321
				120,332	(120,801)			(469)
TOTAL FUNDS				275,414	(265,297)	8,631		18,748
Comparatives	for	movement	in funds
					Net	Transfers
				At	movement	between		At
				1.10.21	in funds	funds		30.9.22
				8	f,			8
Unrestricted	funds
General fund				311,179	28,685	(288)		339,576
Restricted funds
VBG camp				8,570	(4,065)			4,505
Lotte&y funding					7,118			7,118
M BDonation				16,348	(4,755)			11,593
Winston Churchill				7,404	(7,491)		87
JP Morgan				1,000	(1,209)	209
Oak Foundation				67,869	32,965			100,834
Merck/MSP				1,400	(501)			899
Swiss Philanthropy				2,504	(2,496)		(8)
Winston Churchill		2			5,975			5,975
				105,095	25,541	288		130,924
TOTAL FUNDS				416,274	54,226			470,500

		Incoming	Resources	Gains and	Movement
		resources	expended	losses	in funds
			f,
Unrestricted funds
General fund		160,366	(123,747)	(7,934)	28,685
Restricted fun&la
VBG camp		2,028	(6,093)		(4,065)
Lottery funding		9,930	(2,812)		7,118
M B Donation			(4,755)		(4,755)
Winston Churchill			(7,491)		(7,491)
JP Morgan			(1,209)		(1,209)
Oak Foundation		91,360	(58,395)		32,965
Merck/MSP		8,802	(9,303)		(501)
Swiss Philanthropy			(2,496)		(2,496)
Winston Churchill	2	5,975			5,975
		118,095	(92,554)		25,541
TOTAL FUNDS		278,461	(216,301)	(7,934)	54,226

			Net	Transfers
		At	movement	between	At
		1.10,21	in funds	funds	30.9.23
Unrestricted funds
General fund		311,179	47,902	34,194	393,275
Restricted fumls
VBG camp		8,570	(4,065)		4,505
Lottery funding			(138)	138
M B Donation		16,348	(16,348)
Winston Churchill		7,404	(7,491)	87
JP Morgan		1,000	(1,209)	209
Oak Foundation		67,869	31,320	(34,572)	64,617
Merck/MSP		1,400	(1,548)	148
Swiss Philanthropy		2,504	(2,496)	(8)
Winston Churchill	2		9,530		9,530
GSK			196	(196)
Gilead			17,321		17,321
		105,095	25,072	(34,194)	95,973
TOTAL FUNDS		416,274	72,974		489,248

		hlconlnlg	Resources	Gains and	Movement
		resources	expended	losses	in funds
				8
Unrestricted funds
General fund		315,448	(268,243)	697	47,902
Restricted fumls
VBG camp		2,028	(6,093)		(4,065)
Lottery funding		9,930	(10,068)		(138)
M BDonation		4,500	(20,848)		(16,348)
Winston Churchill			(7,491)		(7,491)
JP Morgan			(1,209)		(1,209)
Oak Foundation		177,720	(146,400)		31,320
Merck/MSP		8,802	(10,350)		(1,548)
Swiss Philanthropy			(2,496)		(2,496)
Winston Churchill	2	11,950	(2,420)		9,530
GSK		5,275	(5,079)		196
Gilead		18,222	(901)		17,321
		238,427	(213,355)		25,072
TOTAL FUNDS		553,875	(481,598)	697	72,974